Fast Company Selects Top 10 Most Innovative Companies in Space


Fast Company has released its annual list of the most innovative companies for 2018. The 10 top innovators in the space industry are shown above.

I’m a bit surprised by Stratolaunch landing at no. 10. The aircraft is impressive; I’ve seen it in person outside, and it’s positively Spruce Goosian in its size and ambition. And I’ve been on tarmacs walking around a 747 and an A380, which are also very large airplanes.

That being said, the reality is that the only rocket it available to launch is a Pegasus, whose primary launch aircraft is Orbital ATK’s 44-year old L-1011 that’s parked just down the flight line from the Stratolaunch hangar. They’re working on developing a larger booster for the giant aircraft, so maybe Stratolaunch will be as innovative as Fast Company believes it is at some point. Never say never.

It just seems that Burt Rutan got focused on building the coolest flying vehicle he could while the whole issue of the rocket was not as well thought through. A similar thing happened with SpaceShipTwo, contributing to years of delay.

The other thing is I heard last fall is the Stratolaunch aircraft might not fly until sometime well into next year. So, it could be a while before we see how well that thing actually performs in flight.

ISS U.S. National Lab Payloads Prepped for Orbital ATK CRS-8 Launch

SS John Glenn near the International Space Station. (Credit: NASA)

KENNEDY SPACE CENTER, FL., November 2, 2017 (CASIS) The Orbital ATK Cygnus vehicle is slated to launch to the International Space Station (ISS) no earlier than November 11, 2017 from Wallops Flight Facility.

The Cygnus spacecraft will carry ISS National Laboratory payloads to conduct research across a variety of areas aimed at improving life on Earth. In addition to the diverse research launching to the ISS National Lab, multiple payloads focused on enabling future research missions will be part of the CRS-8 manifest. Thus far in 2017, the ISS National Lab has sponsored more than 100 separate experiments that have reached the station.

(more…)

CASIS, NIH Sponsor Human Physiology & Disease Experiments on ISS

KENNEDY SPACE CENTER, Fla., June 20, 2017 (CASIS PR The Center for the Advancement of Science in Space (CASIS) and the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), today announced five grants have been awarded in response to a funding opportunity focused on human physiology and disease onboard the International Space Station (ISS) U.S. National Laboratory. Data from this research — which will feature “tissue chips” (or “organs-on-chips”) — will help scientists develop and advance novel technologies to improve human health here on Earth.

(more…)

Space Florida, Israel Innovation Authority Announce New Funding Round

EXPLORATION PARK, Fla., and AIRPORT CITY, ISRAEL (Space Florida PR) – Space Florida, the aerospace and spaceport development authority for the State of Florida, and the Israel Innovation Authority, created to maintain Israel’s position at the forefront of global innovation and to elevate the entire economy through technological innovation, announce the fourth-round winners of industrial research and development funding tied to the Space Florida-Israel Innovation Partnership Program.

(more…)

SpacePharma Expands to United States

spacepharma_logoDELEMONT, Switzerland (SpacePharma PR) — Officials with SpacePharma SA, a world leader in providing simplified, high-value microgravity services, today announced the company recently expanded to the United States. SpacePharma, Inc., a wholly owned subsidiary of SpacePharma SA, will introduce American research and pharmaceutical businesses to their unique “one-stop-shop” approach to accessing and taking advantage of microgravity.

“Microgravity is a disruptive environment that enhances and improves a researcher’s ability to make a discovery,” said Yossi Yamin, founder of SpacePharma SA. “But access to microgravity has been limited and expensive – until now. SpacePharma opens up microgravity to all. Through this new division, American customers can take advantage of affordable, end-to-end microgravity services and solutions, all from the comfort of their office. In the end, we will help researchers turn their ideas into realities, including new drugs, food design innovations, advancements in agricultural chemistry and more.”

(more…)

Space Florida, Israel’s Chief Scientist Announce Joint Call for Projects

space_florida_logoKENNEDY SPACE CENTER, Fla., November 6, 2014 (Space Florida PR) – Earlier this week, Space Florida and MATIMOP (Israel’s industrial center for research and development on behalf of the Israeli Chief Scientist Office), issued a joint Call for Projects to fund research and development projects sponsored by companies in both states.

In October 2013, the States of Florida and Israel formed an annually recurring $2 million joint program to support research, development and commercialization of aerospace and related technology projects that benefit both States.

Israeli and Florida-based companies are asked to present cooperative proposals, which will be jointly vetted for feasibility, and research funding will be awarded to companies demonstrating the most promising partnerships – those that demonstrate near-term potential for commercialization and economic benefit to both states.

(more…)

Space Florida-Israel Innovation Program Announces Awards

space_florida_logoKENNEDY SPACE CENTER, Fla., September 17, 2014 (Space Florida PR) – Space Florida and MATIMOP (Israel’s Industrial Center for Research and Development), on behalf of the Office of the Chief Scientist (OCS) in the Israeli Ministry of Economy, are pleased to announce the first-round winners of industrial research and development funding tied to the Space Florida-Israel Innovation Partnership Program.

(more…)

Swiss Space Systems to Launch 28 Satellites for Spacepharma

SOAR spaceplane atop an A-300. (Credit: S3)
SOAR spaceplane atop an A-300. (Credit: S3)

Delémont, Switzerland, 30 September 2013 (S3 PR) — The aerospace company S3 and the Spacepharma SA enterprise, specialised in solutions for medical experiments in microgravity, announce today the signature of a contract relating to the launch of four small satellites in 2018, followed by a monthly launch over two years, making a total of 28 planned launches.

(more…)